{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:18:23Z","timestamp":1793744303416,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2019YFC1709702"],"award-info":[{"award-number":["2019YFC1709702"]}]},{"name":"Research project of Chinese Society of Ethnic Medicine.","award":["2022Z1116-5702111"],"award-info":[{"award-number":["2022Z1116-5702111"]}]},{"name":"the Graduate Research Innovation Practice Project of Chengdu University of Traditional Chinese Medicine","award":["CXZD2021009"],"award-info":[{"award-number":["CXZD2021009"]}]},{"name":"the Science and Technology Development Fund Project of Hospital of Chengdu University of TCM","award":["18MZ09"],"award-info":[{"award-number":["18MZ09"]}]},{"name":"the Special Project of \u201cXinglin Scholars\u201d Scientific Research Promotion Program of Chengdu University of TCM","award":["FSYY147"],"award-info":[{"award-number":["FSYY147"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenera\u00adtive disorder after Alzheimer disease accompanied by the death of dopaminergic neurons and brain nigrostriatal mitochondrial damage in the elderly population. The features of the disease include tremor, rigidity, postural instability, and motor retardation. The pathogenesis of Parkinson\u2019s disease is complex, and abnormal lipid metabolism resulting in ferroptosis due to the excessive accumulation of free radicals from oxidative stress in the substantia nigra of the brain was thought to be one of the factors causing the disease. Morroniside has been reported to have significant neuroprotective effects, although it has not been studied in PD. Therefore, this study focused on determining the neuroprotective effects of morroniside (25, 50, and 100\u00a0mg\/kg) on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 30\u00a0mg\/kg)-induced mice models of PD and explored 1-methyl-4-phenylpyridinium MPP+-induced ferroptosis in PC12 cells. Morroniside restored impaired motor function in the PD mice models while reducing neuronal injury. The activation of nuclear factor erythroid 2-related factor 2\/antioxidant response elements (Nrf2\/ARE) by morroniside promoted antioxidation, the content of reducing agent glutathione (GSH) increased, and the level of the lipid metabolite malondialdehyde (MDA) decreased. Notably, morroniside inhibited ferroptosis in substantia nigra of the brain and PC12 cells, reduced iron levels, and upregulated the expression of the iron-regulated proteins glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), ferritin heavy chain 1 (FTH-1), and ferroportin (FPN). More importantly, morroniside repaired the mitochondrial damage, restored the mitochondrial respiratory chain, and inhibited the production of reactive oxygen species (ROS). These data indicated that morroniside could activate the Nrf2\/ARE signaling pathway to increase the antioxidant capacity, thereby inhibiting abnormal lipid metabolism and protecting dopaminergic neurons from ferroptosis in PD.<\/jats:p>","DOI":"10.1186\/s12906-023-03967-0","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T06:02:07Z","timestamp":1688191327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson\u2019s disease via inhibiting oxidative stress and ferroptosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Mao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianrong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"3967_CR1","doi-asserted-by":"publisher","unstructured":"(2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:46. https:\/\/doi.org\/10.1038\/s41572-021-00286-x.","DOI":"10.1038\/s41572-021-00286-x"},{"key":"3967_CR2","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.4103\/1673-5374.306066","volume":"16","author":"SN Rai","year":"2021","unstructured":"Rai SN, Singh P, Varshney R, Chaturvedi VK, Vamanu E, Singh MP, Singh BK. Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease. Neural Regen Res. 2021;16:1730\u20139. https:\/\/doi.org\/10.4103\/1673-5374.306066.","journal-title":"Neural Regen Res"},{"key":"3967_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s13205-020-02532-7","volume":"10","author":"SN Rai","year":"2020","unstructured":"Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh MP. Mucuna pruriens in Parkinson\u2019s and in some other diseases: recent advancement and future prospective. 3 Biotech. 2020;10:522. https:\/\/doi.org\/10.1007\/s13205-020-02532-7.","journal-title":"3 Biotech"},{"key":"3967_CR4","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.jchemneu.2020.101752","volume":"104","author":"SN Rai","year":"2020","unstructured":"Rai SN, Singh P. Advancement in the modelling and therapeutics of Parkinson\u2019s disease. J Chem Neuroanat. 2020;104:101752. https:\/\/doi.org\/10.1016\/j.jchemneu.2020.101752.","journal-title":"J Chem Neuroanat"},{"key":"3967_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.stem.2021.03.010","volume":"28","author":"JS Schweitzer","year":"2021","unstructured":"Schweitzer JS, Song B, Kim KS. A step closer to autologous cell therapy for Parkinson\u2019s disease. Cell Stem Cell. 2021;28:595\u20137. https:\/\/doi.org\/10.1016\/j.stem.2021.03.010.","journal-title":"Cell Stem Cell"},{"key":"3967_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","volume":"20","author":"N Vijiaratnam","year":"2021","unstructured":"Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson\u2019s disease. Lancet Neurol. 2021;20:559\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(21)00061-2.","journal-title":"Lancet Neurol"},{"key":"3967_CR7","doi-asserted-by":"publisher","first-page":"368ra174","DOI":"10.1126\/scitranslmed.aag2210","volume":"8","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson\u2019s disease. Sci Transl Med. 2016;8:368ra174. https:\/\/doi.org\/10.1126\/scitranslmed.aag2210.","journal-title":"Sci Transl Med"},{"key":"3967_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","volume":"19","author":"R de Bie","year":"2020","unstructured":"de Bie R, Clarke CE, Espay AJ, Fox SH, Lang AE. Initiation of pharmacological therapy in Parkinson\u2019s disease: when, why, and how. Lancet Neurol. 2020;19:452\u201361. https:\/\/doi.org\/10.1016\/S1474-4422(20)30036-3.","journal-title":"Lancet Neurol"},{"key":"3967_CR9","doi-asserted-by":"publisher","first-page":"120453","DOI":"10.1016\/j.ijpharm.2021.120453","volume":"599","author":"S Di Gioia","year":"2021","unstructured":"Di Gioia S, Trapani A, Cassano R, Di Gioia ML, Trombino S, Cellamare S, Bolognino I, Hossain MN, Sanna E, Trapani G, Conese M. Nose-to-brain delivery: a comparative study between carboxymethyl chitosan based conjugates of dopamine. Int J Pharm. 2021;599:120453. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120453.","journal-title":"Int J Pharm"},{"key":"3967_CR10","doi-asserted-by":"publisher","first-page":"101263","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"PA Dion\u00edsio","year":"2021","unstructured":"Dion\u00edsio PA, Amaral JD, Rodrigues C. Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Res Rev. 2021;67:101263. https:\/\/doi.org\/10.1016\/j.arr.2021.101263.","journal-title":"Ageing Res Rev"},{"key":"3967_CR11","doi-asserted-by":"publisher","first-page":"101207","DOI":"10.1016\/j.arr.2020.101207","volume":"65","author":"W Zhang","year":"2021","unstructured":"Zhang W, Feng C, Jiang H. Novel target for treating Alzheimer\u2019s Diseases: crosstalk between the Nrf2 pathway and autophagy. Ageing Res Rev. 2021;65:101207. https:\/\/doi.org\/10.1016\/j.arr.2020.101207.","journal-title":"Ageing Res Rev"},{"key":"3967_CR12","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1089\/ars.2010.3731","volume":"14","author":"A Jazwa","year":"2011","unstructured":"Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fern\u00e1ndez-Ruiz J, Cuadrado A. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal. 2011;14:2347\u201360. https:\/\/doi.org\/10.1089\/ars.2010.3731.","journal-title":"Antioxid Redox Signal"},{"key":"3967_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/ars.2011.4491","volume":"18","author":"NA Kaidery","year":"2013","unstructured":"Kaidery NA, Banerjee R, Yang L, Smirnova NA, Hushpulian DM, Liby KT, Williams CR, Yamamoto M, Kensler TW, Ratan RR, Sporn MB, Beal MF, Gazaryan IG, Thomas B. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson\u2019s disease. Antioxid Redox Signal. 2013;18:139\u201357. https:\/\/doi.org\/10.1089\/ars.2011.4491.","journal-title":"Antioxid Redox Signal"},{"key":"3967_CR14","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1073\/pnas.0607260103","volume":"103","author":"CM Clements","year":"2006","unstructured":"Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer- and Parkinson\u2019s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A. 2006;103:15091\u20136. https:\/\/doi.org\/10.1073\/pnas.0607260103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3967_CR15","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"key":"3967_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"B Do Van","year":"2016","unstructured":"Do Van B, Gouel F, Jonneaux A, Timmerman K, Gel\u00e9 P, P\u00e9trault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC. Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC. Neurobiol Dis. 2016;94:169\u201378. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.011.","journal-title":"Neurobiol Dis"},{"key":"3967_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/med.21712","volume":"41","author":"PR Angelova","year":"2021","unstructured":"Angelova PR, Esteras N, Abramov AY. Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention. Med Res Rev. 2021;41:770\u201384. https:\/\/doi.org\/10.1002\/med.21712.","journal-title":"Med Res Rev"},{"key":"3967_CR18","doi-asserted-by":"publisher","unstructured":"Wu H, Wang F, Ta N, Zhang T, Gao W. The multifaceted regulation of Mitochondria in Ferroptosis. Life (Basel). 2021;11. https:\/\/doi.org\/10.3390\/life11030222.","DOI":"10.3390\/life11030222"},{"key":"3967_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5.","journal-title":"Cell Res"},{"key":"3967_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","volume":"39","author":"MT Islam","year":"2017","unstructured":"Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73\u201382. https:\/\/doi.org\/10.1080\/01616412.2016.1251711.","journal-title":"Neurol Res"},{"key":"3967_CR21","doi-asserted-by":"publisher","first-page":"112232","DOI":"10.1016\/j.phytochem.2019.112232","volume":"171","author":"XS Ye","year":"2020","unstructured":"Ye XS, He J, Xu JK, He XL, Xia CY, Yan Y, Lian WW, Zhang WK. Undescribed morroniside-like secoiridoid diglycosides with \u03b1-glucosidase inhibitory activity from Corni Fructus. Phytochemistry. 2020;171:112232. https:\/\/doi.org\/10.1016\/j.phytochem.2019.112232.","journal-title":"Phytochemistry"},{"key":"3967_CR22","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3892\/etm.2018.6457","volume":"16","author":"G Zeng","year":"2018","unstructured":"Zeng G, Ding W, Li Y, Sun M, Deng L. Morroniside protects against cerebral ischemia\/reperfusion injury by inhibiting neuron apoptosis and MMP2\/9 expression. Exp Ther Med. 2018;16:2229\u201334. https:\/\/doi.org\/10.3892\/etm.2018.6457.","journal-title":"Exp Ther Med"},{"key":"3967_CR23","doi-asserted-by":"publisher","first-page":"105105","DOI":"10.1016\/j.neuint.2021.105105","volume":"148","author":"FX Duan","year":"2021","unstructured":"Duan FX, Shi YJ, Chen J, Song X, Shen L, Qi Q, Ding SQ, Wang QY, Wang R, L\u00fc HZ, Hu JG. The neuroprotective role of morroniside against spinal cord injury in female rats. Neurochem Int. 2021;148:105105. https:\/\/doi.org\/10.1016\/j.neuint.2021.105105.","journal-title":"Neurochem Int"},{"key":"3967_CR24","doi-asserted-by":"publisher","first-page":"108926","DOI":"10.1016\/j.abb.2021.108926","volume":"706","author":"C Park","year":"2021","unstructured":"Park C, Cha HJ, Lee H, Kim GY, Choi YH. The regulation of the TLR4\/NF-\u03baB and Nrf2\/HO-1 signaling pathways is involved in the inhibition of lipopolysaccharide-induced inflammation and oxidative reactions by morroniside in RAW 264.7 macrophages. Arch Biochem Biophys. 2021;706:108926. https:\/\/doi.org\/10.1016\/j.abb.2021.108926.","journal-title":"Arch Biochem Biophys"},{"key":"3967_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.brainresbull.2010.07.003","volume":"83","author":"W Wang","year":"2010","unstructured":"Wang W, Xu J, Li L, Wang P, Ji X, Ai H, Zhang L, Li L. Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res Bull. 2010;83:196\u2013201. https:\/\/doi.org\/10.1016\/j.brainresbull.2010.07.003.","journal-title":"Brain Res Bull"},{"key":"3967_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-0773.1996.tb00259.x","volume":"79","author":"AL Rodrigues","year":"1996","unstructured":"Rodrigues AL, Rocha JB, Mello CF, Souza DO. Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. Pharmacol Toxicol. 1996;79:150\u20136. https:\/\/doi.org\/10.1111\/j.1600-0773.1996.tb00259.x.","journal-title":"Pharmacol Toxicol"},{"key":"3967_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0165-0270(96)02211-x","volume":"73","author":"K Matsuura","year":"1997","unstructured":"Matsuura K, Kabuto H, Makino H, Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 1997;73:45\u20138. https:\/\/doi.org\/10.1016\/s0165-0270(96)02211-x.","journal-title":"J Neurosci Methods"},{"key":"3967_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2020.00612","volume":"14","author":"S Tai","year":"2020","unstructured":"Tai S, Zheng Q, Zhai S, Cai T, Xu L, Yang L, Jiao L, Zhang C. Alpha-lipoic acid mediates clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson\u2019s Disease Model Induced by 6-OHDA. Front Neurosci. 2020;14:612. https:\/\/doi.org\/10.3389\/fnins.2020.00612.","journal-title":"Front Neurosci"},{"key":"3967_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.redox.2018.05.015","volume":"18","author":"J Lee","year":"2018","unstructured":"Lee J, Song K, Huh E, Oh MS, Kim YS. Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara. Redox Biol. 2018;18:6\u201315. https:\/\/doi.org\/10.1016\/j.redox.2018.05.015.","journal-title":"Redox Biol"},{"key":"3967_CR30","doi-asserted-by":"publisher","unstructured":"Cui W, Zhan Y, Shao X, Fu W, Xiao D, Zhu J, Qin X, Zhang T, Zhang M, Zhou Y, Lin Y (2019) Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson\u2019s Disease in Vitro. ACS Appl Mater Interfaces 11:32787\u201332797. https:\/\/doi.org\/10.1021\/acsami.9b10308.","DOI":"10.1021\/acsami.9b10308"},{"key":"3967_CR31","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1021\/acsnano.9b06453","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Liu C, Zhang J, Zhang Y, Liu K, Song JX, Sreenivasmurthy SG, Wang Z, Shi Y, Chu C, Zhang Y, Wu C, Deng X, Liu X, Song J, Zhuang R, Huang S, Zhang P, Li M, Wen L, Zhang YW, Liu G. A self-assembled \u03b1-Synuclein nanoscavenger for Parkinson\u2019s Disease. ACS Nano. 2020;14:1533\u201349. https:\/\/doi.org\/10.1021\/acsnano.9b06453.","journal-title":"ACS Nano"},{"key":"3967_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20:385\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"key":"3967_CR33","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell. 2019;18:e13031. https:\/\/doi.org\/10.1111\/acel.13031.","journal-title":"Aging Cell"},{"key":"3967_CR34","doi-asserted-by":"publisher","first-page":"1370837","DOI":"10.1155\/2020\/1370837","volume":"2020","author":"MA Robea","year":"2020","unstructured":"Robea MA, Balmus IM, Ciobica A, Strungaru S, Plavan G, Gorgan LD, Savuca A, Nicoara M. Parkinson\u2019s Disease-Induced zebrafish models: focussing on oxidative stress implications and sleep processes. Oxid Med Cell Longev. 2020;2020:1370837. https:\/\/doi.org\/10.1155\/2020\/1370837.","journal-title":"Oxid Med Cell Longev"},{"key":"3967_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","volume":"104","author":"SJ Guiney","year":"2017","unstructured":"Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S. Ferroptosis and cell death mechanisms in Parkinson\u2019s disease. Neurochem Int. 2017;104:34\u201348. https:\/\/doi.org\/10.1016\/j.neuint.2017.01.004.","journal-title":"Neurochem Int"},{"key":"3967_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41401-018-0077-8","volume":"40","author":"ZL Ren","year":"2019","unstructured":"Ren ZL, Wang CD, Wang T, Ding H, Zhou M, Yang N, Liu YY, Chan P. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacol Sin. 2019;40:441\u201350. https:\/\/doi.org\/10.1038\/s41401-018-0077-8.","journal-title":"Acta Pharmacol Sin"},{"key":"3967_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","volume":"11","author":"Z Wei","year":"2018","unstructured":"Wei Z, Li X, Li X, Liu Q, Cheng Y. Oxidative stress in Parkinson\u2019s Disease: a systematic review and Meta-analysis. Front Mol Neurosci. 2018;11:236. https:\/\/doi.org\/10.3389\/fnmol.2018.00236.","journal-title":"Front Mol Neurosci"},{"key":"3967_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12640-019-00038-6","volume":"36","author":"SN Rai","year":"2019","unstructured":"Rai SN, Zahra W, Singh SS, Birla H, Keswani C, Dilnashin H, Rathore AS, Singh R, Singh RK, Singh SP. Anti-inflammatory activity of Ursolic Acid in MPTP-Induced Parkinsonian Mouse Model. Neurotox Res. 2019;36:452\u201362. https:\/\/doi.org\/10.1007\/s12640-019-00038-6.","journal-title":"Neurotox Res"},{"key":"3967_CR39","doi-asserted-by":"publisher","first-page":"6571484","DOI":"10.1155\/2020\/6571484","volume":"2020","author":"SS Singh","year":"2020","unstructured":"Singh SS, Rai SN, Birla H, Zahra W, Rathore AS, Dilnashin H, Singh R, Singh SP. Neuroprotective effect of Chlorogenic Acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian Mouse Model. Oxid Med Cell Longev. 2020;2020:6571484. https:\/\/doi.org\/10.1155\/2020\/6571484.","journal-title":"Oxid Med Cell Longev"},{"key":"3967_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2174\/138161211795164095","volume":"17","author":"RD Prediger","year":"2011","unstructured":"Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson\u2019s disease. Curr Pharm Des. 2011;17:489\u2013507. https:\/\/doi.org\/10.2174\/138161211795164095.","journal-title":"Curr Pharm Des"},{"key":"3967_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/exnr.2002.8021","volume":"178","author":"JL Tillerson","year":"2002","unstructured":"Tillerson JL, Caudle WM, Rever\u00f3n ME, Miller GW. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol. 2002;178:80\u201390. https:\/\/doi.org\/10.1006\/exnr.2002.8021.","journal-title":"Exp Neurol"},{"key":"3967_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s11655-018-2935-5","volume":"24","author":"SM Liu","year":"2018","unstructured":"Liu SM, Li XZ, Zhang SN, Yang ZM, Wang KX, Lu F, Wang CZ, Yuan CS. Acanthopanax senticosus protects structure and function of Mesencephalic Mitochondria in A Mouse Model of Parkinson\u2019s Disease. Chin J Integr Med. 2018;24:835\u201343. https:\/\/doi.org\/10.1007\/s11655-018-2935-5.","journal-title":"Chin J Integr Med"},{"key":"3967_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0964528421990658","volume":"39","author":"QQ Han","year":"2021","unstructured":"Han QQ, Fu Y, Le JM, Pilot A, Cheng S, Chen PQ, Wu H, Wan GQ, Gu XF. Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson\u2019s disease. Acupunct Med. 2021;39:501\u201311. https:\/\/doi.org\/10.1177\/0964528421990658.","journal-title":"Acupunct Med"},{"key":"3967_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00441-004-0918-2","volume":"318","author":"U Misgeld","year":"2004","unstructured":"Misgeld U. Innervation of the substantia nigra. Cell Tissue Res. 2004;318:107\u201314. https:\/\/doi.org\/10.1007\/s00441-004-0918-2.","journal-title":"Cell Tissue Res"},{"key":"3967_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S. Understanding dopaminergic cell death pathways in Parkinson Disease. Neuron. 2016;90:675\u201391. https:\/\/doi.org\/10.1016\/j.neuron.2016.03.038.","journal-title":"Neuron"},{"key":"3967_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys. 2011;508:1\u201312. https:\/\/doi.org\/10.1016\/j.abb.2010.12.017.","journal-title":"Arch Biochem Biophys"},{"key":"3967_CR47","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1007\/s12035-018-1256-9","volume":"56","author":"MF Salvatore","year":"2019","unstructured":"Salvatore MF, McInnis TR, Cantu MA, Apple DM, Pruett BS. Tyrosine hydroxylase inhibition in Substantia Nigra decreases Movement frequency. Mol Neurobiol. 2019;56:2728\u201340. https:\/\/doi.org\/10.1007\/s12035-018-1256-9.","journal-title":"Mol Neurobiol"},{"key":"3967_CR48","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00702-016-1596-4","volume":"123","author":"T Nagatsu","year":"2016","unstructured":"Nagatsu T, Nagatsu I. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson\u2019s disease (PD): historical overview and future prospects. J Neural Transm (Vienna). 2016;123:1255\u201378. https:\/\/doi.org\/10.1007\/s00702-016-1596-4.","journal-title":"J Neural Transm (Vienna)"},{"key":"3967_CR49","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1016\/j.febslet.2015.10.002","volume":"589","author":"H Rekaik","year":"2015","unstructured":"Rekaik H, Blaudin de Th\u00e9 FX, Prochiantz A, Fuchs J, Joshi RL. Dissecting the role of Engrailed in adult dopaminergic neurons\u2013insights into Parkinson disease pathogenesis. FEBS Lett. 2015;589:3786\u201394. https:\/\/doi.org\/10.1016\/j.febslet.2015.10.002.","journal-title":"FEBS Lett"},{"key":"3967_CR50","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/jnr.21975","volume":"87","author":"A Siebert","year":"2009","unstructured":"Siebert A, Desai V, Chandrasekaran K, Fiskum G, Jafri MS. Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J Neurosci Res. 2009;87:1659\u201369. https:\/\/doi.org\/10.1002\/jnr.21975.","journal-title":"J Neurosci Res"},{"key":"3967_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/exnr.1997.6752","volume":"150","author":"HM Schipper","year":"1998","unstructured":"Schipper HM, Liberman A, Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson\u2019s disease. Exp Neurol. 1998;150:60\u20138. https:\/\/doi.org\/10.1006\/exnr.1997.6752.","journal-title":"Exp Neurol"},{"key":"3967_CR52","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1073\/pnas.0813361106","volume":"106","author":"PC Chen","year":"2009","unstructured":"Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: critical role for the astrocyte. Proc Natl Acad Sci U S A. 2009;106:2933\u20138. https:\/\/doi.org\/10.1073\/pnas.0813361106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3967_CR53","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","volume":"1780","author":"SJ Chinta","year":"2008","unstructured":"Chinta SJ, Andersen JK. Redox imbalance in Parkinson\u2019s disease. Biochim Biophys Acta. 2008;1780:1362\u20137. https:\/\/doi.org\/10.1016\/j.bbagen.2008.02.005.","journal-title":"Biochim Biophys Acta"},{"key":"3967_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/BC.2009.033","volume":"390","author":"N Ballatori","year":"2009","unstructured":"Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390:191\u2013214. https:\/\/doi.org\/10.1515\/BC.2009.033.","journal-title":"Biol Chem"},{"key":"3967_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"key":"3967_CR56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X. Role of Mitochondria in Ferroptosis. Mol Cell. 2019;73:354\u2013363e3. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.042.","journal-title":"Mol Cell"},{"key":"3967_CR57","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.bbamcr.2018.12.012","volume":"1866","author":"L Sedlackova","year":"2019","unstructured":"Sedlackova L, Korolchuk VI. Mitochondrial quality control as a key determinant of cell survival. Biochim Biophys Acta Mol Cell Res. 2019;1866:575\u201387. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.12.012.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3967_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.18926\/AMO\/30942","volume":"62","author":"I Miyazaki","year":"2008","unstructured":"Miyazaki I, Asanuma M. Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama. 2008;62:141\u201350. https:\/\/doi.org\/10.18926\/AMO\/30942.","journal-title":"Acta Med Okayama"},{"key":"3967_CR59","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1021\/acschemneuro.8b00276","volume":"9","author":"A Biosa","year":"2018","unstructured":"Biosa A, Arduini I, Soriano ME, Giorgio V, Bernardi P, Bisaglia M, Bubacco L. Dopamine Oxidation Products as mitochondrial endotoxins, a potential molecular mechanism for preferential neurodegeneration in Parkinson\u2019s Disease. ACS Chem Neurosci. 2018;9:2849\u201358. https:\/\/doi.org\/10.1021\/acschemneuro.8b00276.","journal-title":"ACS Chem Neurosci"},{"key":"3967_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tips.2012.03.008","volume":"33","author":"HM Gao","year":"2012","unstructured":"Gao HM, Zhou H, Hong JS. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci. 2012;33:295\u2013303. https:\/\/doi.org\/10.1016\/j.tips.2012.03.008.","journal-title":"Trends Pharmacol Sci"},{"key":"3967_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.mehy.2014.01.013","volume":"82","author":"S Brenner","year":"2014","unstructured":"Brenner S. Parkinson\u2019s disease may be due to failure of melanin in the Substantia Nigra to produce molecular hydrogen from dissociation of water, to protect the brain from oxidative stress. Med Hypotheses. 2014;82:503. https:\/\/doi.org\/10.1016\/j.mehy.2014.01.013.","journal-title":"Med Hypotheses"},{"key":"3967_CR62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295\u2013322. https:\/\/doi.org\/10.1146\/annurev.pharmtox.011008.145533.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3967_CR63","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"3967_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175\u201385. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.027.","journal-title":"Free Radic Biol Med"},{"key":"3967_CR65","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","volume":"17","author":"Y Tian","year":"2020","unstructured":"Tian Y, Lu J, Hao X, Li H, Zhang G, Liu X, Li X, Zhao C, Kuang W, Chen D, Zhu M. FTH1 inhibits ferroptosis through Ferritinophagy in the 6-OHDA model of Parkinson\u2019s Disease. Neurotherapeutics. 2020;17:1796\u2013812. https:\/\/doi.org\/10.1007\/s13311-020-00929-z.","journal-title":"Neurotherapeutics"},{"key":"3967_CR66","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.26355\/eurrev_201806_15267","volume":"22","author":"N Geng","year":"2018","unstructured":"Geng N, Shi BJ, Li SL, Zhong ZY, Li YC, Xua WL, Zhou H, Cai JH. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. Eur Rev Med Pharmacol Sci. 2018;22:3826\u201336. https:\/\/doi.org\/10.26355\/eurrev_201806_15267.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3967_CR67","doi-asserted-by":"publisher","unstructured":"Reichert CO, de Freitas FA, Sampaio-Silva J, Rokita-Rosa L, Barros PL, Levy D, Bydlowski SP. Ferroptosis mechanisms involved in neurodegenerative Diseases. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21228765.","DOI":"10.3390\/ijms21228765"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-03967-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T06:04:17Z","timestamp":1688191457000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-03967-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3967"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-03967-0","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not include human participants. The procedures for animal care and use have been approved by the Ethics Committee of Chengdu University of Traditional Chinese Medicine. Animal care and procedures comply with the ethical guidelines issued by the International Scientific Committee on Experimental Animals (ICLAS). The study is reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study was reviewed and approved by Chengdu University of Traditional Chinese Medicine (No. 20211498\u00a0A).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"218"}}